Cell Bio Human Tech Co.,Ltd (KOSDAQ: 318160)

Cell Bio Human Tech Co.,Ltd Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Oct 10, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	27,831	37,862	-	-	-	-
Enterprise Value	17,695	33,014	-	-	-	-
Last Close Price	3155.00	4090.00	-	-	-	-
PE Ratio	32.36	-18.59	-	-	-	-
PS Ratio	1.03	1.39	-	-	-	-
PB Ratio	0.64	0.85	-	-	-	-
P/FCF Ratio	4.23	33.46	-	-	-	-
P/OCF Ratio	5.13	21.52	-	-	-	-
EV/Sales Ratio	0.64	1.21	-	-	-	-
EV/EBITDA Ratio	3.54	6.67	-	-	-	-
EV/EBIT Ratio	5.44	10.48	-	-	-	-
EV/FCF Ratio	2.69	29.18	-	-	-	-
Debt / Equity Ratio	0.14	0.13	0.14	0.38	0.02	0.01
Debt / EBITDA Ratio	1.24	1.20	0.97	2.05	0.11	0.09
Debt / FCF Ratio	0.94	5.24	67.51	3.77	-0.07	0.13
Asset Turnover	0.53	0.55	0.53	0.66	0.59	0.67
Inventory Turnover	2.46	2.25	2.59	4.69	5.25	6.46
Quick Ratio	2.55	2.08	1.29	2.61	5.74	16.12
Current Ratio	3.24	3.15	2.57	3.33	7.35	17.49
Return on Equity (ROE)	2.02%	-4.49%	7.52%	7.51%	9.19%	13.12%
Return on Assets (ROA)	3.84%	3.97%	4.25%	6.62%	6.77%	8.14%
Return on Capital (ROIC)	4.01%	4.20%	4.57%	7.13%	7.12%	8.63%
Earnings Yield	3.09%	-4.90%	-	-	-	-
FCF Yield	23.66%	2.99%	-	-	-	-
Buyback Yield / Dilution	-23.42%	-20.68%	11.32%	1.95%	1.05%	-1.21%
Total Shareholder Return	-23.42%	-20.68%	11.32%	1.95%	1.05%	-1.21%

Source: S&P Capital IQ. Standard template. Financial Sources.